ScoreWhy is Tasly Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of -9.48% and Operating profit at -2.22% over the last 5 years
2
Negative results in Dec 25
- OPERATING CASH FLOW(Y) Lowest at CNY 912.93 MM
- NET PROFIT(Q) At CNY 112.86 MM has Fallen at -55.59%
- DIVIDEND PAYOUT RATIO(Y) Lowest at 0%
3
Below par performance in long term as well as near term
- Along with generating -5.94% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Tasly Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tasly Pharmaceutical Group Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Tasly Pharmaceutical Group Co., Ltd.
-2.84%
0.15
18.40%
China Shanghai Composite
8.25%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.02%
EBIT Growth (5y)
1.96%
EBIT to Interest (avg)
26.04
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.59
Tax Ratio
18.31%
Dividend Payout Ratio
41.91%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
10.65%
ROE (avg)
10.17%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
1.55
EV to EBIT
13.53
EV to EBITDA
10.77
EV to Capital Employed
1.61
EV to Sales
2.22
PEG Ratio
NA
Dividend Yield
2.35%
ROCE (Latest)
11.90%
ROE (Latest)
7.63%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 2,297.92 MM
ROCE(HY)
Highest at 9.4%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
RAW MATERIAL COST(Y)
Fallen by -10.38% (YoY
-1What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.6 times
Here's what is working for Tasly Pharmaceutical Group Co., Ltd.
Operating Cash Flow
Highest at CNY 2,297.92 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Raw Material Cost
Fallen by -10.38% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Tasly Pharmaceutical Group Co., Ltd.
Inventory Turnover Ratio
Lowest at 1.6 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
